ENTITY

Ranbaxy Laboratories (RBXY IN)

9
Analysis
Health CareIndia
Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).
more
bearishMankind Pharma
26 Jan 2023 11:46

Mankind Pharma Pre-IPO - The Negatives - Recent Updates Weren't Great

Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.

Logo
454 Views
Share
bullishMankind Pharma
25 Jan 2023 10:05

Mankind Pharma Pre-IPO - The Positives - Diverse Portfolio with Steady past Performance

Mankind Pharma  is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.

Logo
383 Views
Share
19 Nov 2020 13:36

Gland Pharma IPO Trading - Squeezed Through, Now for the Real Test

Gland Pharma raised around US$900m in one of India’s largest IPOs in 2020. The company was established in 1978. KKR invested in 2014 and Fosun...

Logo
362 Views
Share
13 Apr 2018 15:14

IPCA Labs- The Revival Story

Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...

Logo
185 Views
Share
28 Jan 2017 19:36

HealthCare Global Enterprises (HCG)- A Niche Play in Burgeoning Indian Healthcare Sector

HealthCare Global Enterprises Limited (HCG IN) is a speciality healthcare provider with a focus on cancer and infertility treatment. It is the...

x